Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)
Clinical trial NCT04137224 · COMPLETED
Trial details
- NCT number
- NCT04137224
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-19
- Primary completion
- 2022-05-17
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.